Endovascular Today - Latest News http://evtoday.com/ The latest news stories from Endovascular Today. en-us Sun, 9 Jul 2017 17:53:55 GMT Sun, 9 Jul 2017 17:53:55 GMT BMCToday Financing Will Support Clinical Development of Evasc's eClips Cerebral Aneurysm Repair System http://evtoday.com/2017/07/07/financing-will-support-clinical-development-of-evascs-eclips-cerebral-aneurysm-repair-system July 7, 2017 -- Evasc Neurovascular Enterprises ULC, the developer of the eClips system for cerebral aneurysm repair, recently announced that it has closed Series A venture capital financing round in the amount of Can $10 million. Evasc's eClips have received approval for use in Canada under the Special Access Program i... Fri, 7 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/07/financing-will-support-clinical-development-of-evascs-eclips-cerebral-aneurysm-repair-system Get With the Guidelines Program Launched in China to Improve Stroke Outcomes http://evtoday.com/2017/07/06/get-with-the-guidelines-program-launched-in-china-to-improve-stroke-outcomes July 6, 2017 -- The American Heart Association/American Stroke Association (AHA/ASA) announced a collaboration with the Chinese Stroke Association (CSA) to launch a quality improvement program adapted from the AHA's guidelines-based program, Get With the Guidelines (GWTG), with the aim of delivering significant, positiv... Thu, 6 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/06/get-with-the-guidelines-program-launched-in-china-to-improve-stroke-outcomes Arizona Adopts New Emergency Guidelines to Improve Stroke Triage http://evtoday.com/2017/07/06/arizona-adopts-new-emergency-guidelines-to-improve-stroke-triage July 6, 2017 -- The Society of NeuroInterventional Surgery (SNIS) and its Get Ahead of Stroke public education and advocacy campaign announced that the state of Arizona has enacted new emergency guidelines that improve stroke triage to increase survival rates and reduce long-term care costs. The Arizona Governor’s ... Thu, 6 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/06/arizona-adopts-new-emergency-guidelines-to-improve-stroke-triage Endografts With Suprarenal Versus Infrarenal Fixation Compared for Renal Complications http://evtoday.com/2017/07/06/endografts-with-suprarenal-versus-infrarenal-fixation-compared-for-renal-complications July 6, 2017 -- A study comparing renal complications between endografts with suprarenal or infrarenal fixation was published by Sara L. Zettervall, MD, et al in European Journal of Vascular and Endovascular Surgery (EJVES; 2017;54:5 -- 11). In this study, the investigators aimed to compare the outcomes of contemporary s... Thu, 6 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/06/endografts-with-suprarenal-versus-infrarenal-fixation-compared-for-renal-complications Cerus Endovascular's Contour Neurovascular System Approved in Europe  http://evtoday.com/2017/07/06/cerus-endovasculars-contour-neurovascular-system-approved-in-europe July 6, 2017 -- Cerus Endovascular Ltd announced that it has received CE Mark approval for the commercial sale of its Contour neurovascular system for treating intracranial aneurysms across the European Union. The company intends to initiate a controlled commercial rollout in select countries that recognize the CE Mark thro... Thu, 6 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/06/cerus-endovasculars-contour-neurovascular-system-approved-in-europe BIOFLEX-I Pivotal Trial Results Presented for Biotronik's Pulsar-18 Stent to Treat SFA Disease http://evtoday.com/2017/07/05/bioflex-i-pivotal-trial-results-presented-for-biotroniks-pulsar-18-stent-to-treat-sfa-disease July 5, 2017 -- Biotronik announced the results of the BIOFLEX-I clinical study and the commercial availability of the company's Pulsar-18 self-expanding stent for the treatment of patients with peripheral artery disease (PAD). The study results were presented during a late-breaking trial session at C3: the 2017 Complex... Wed, 5 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/05/bioflex-i-pivotal-trial-results-presented-for-biotroniks-pulsar-18-stent-to-treat-sfa-disease Sirtex's SIR-Spheres Y-90 Resin Microspheres Analyzed in Patients With Liver Metastases From Right-Sided Primary Colon Cancer http://evtoday.com/2017/07/05/sirtexs-sir-spheres-y-90-resin-microspheres-analyzed-in-patients-with-liver-metastases-from-right-sided-primary-colon-cancer July 5, 2017 -- Sirtex Medical Inc. announced findings from a post hoc data analysis from the 739-patient SIRFLOX and FOXFIRE Global studies. Prof. Guy van Hazel, MD, presented the data at the European Society of Medical Oncology's 19th World Congress on Gastrointestinal Cancer (WCGC) held June 28 to July 1 in Barcelona... Wed, 5 Jul 2017 04:00:00 GMT http://evtoday.com/2017/07/05/sirtexs-sir-spheres-y-90-resin-microspheres-analyzed-in-patients-with-liver-metastases-from-right-sided-primary-colon-cancer Results Published for Bio2 Medical's Angel Catheter Pivotal Study http://evtoday.com/2017/06/29/results-published-for-bio2-medicals-angel-catheter-pivotal-study June 29, 2017 -- Bio2 Medical announced that the results of the pivotal study for the company's Angel catheter were published by Victor F. Tapson, MD, et al online ahead of print in Journal of Vascular and Interventional Radiology (JVIR). The study met all safety endpoints and showed that the Angel catheter demonstrated... Thu, 29 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/29/results-published-for-bio2-medicals-angel-catheter-pivotal-study Royal Philips Acquires CardioProlific http://evtoday.com/2017/06/29/royal-philips-acquires-cardioprolific June 29, 2017 -- Royal Philips announced the acquisition of CardioProlific Inc., which is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial details of the transaction will not be disclosed. CardioProlific is a privately held company based in California. According to Philips... Thu, 29 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/29/royal-philips-acquires-cardioprolific Royal Philips to Acquire Spectranetics Corporation http://evtoday.com/2017/06/28/royal-philips-to-acquire-spectranetics-corporation June 28, 2017 -- Royal Philips and Spectranetics Corporation announced that they have entered into a definitive merger agreement. Philips will tender offers to shareholders for all issued and outstanding shares of Spectranetics in a deal estimated at €1.9 billion. According to Philips, the acquisition of Spectraneti... Wed, 28 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/28/royal-philips-to-acquire-spectranetics-corporation Female Sex Studied as an Independent Predictor of Mortality After TEVAR for Intact Descending TAA http://evtoday.com/2017/06/28/female-sex-studied-as-an-independent-predictor-of-mortality-after-tevar-for-intact-descending-taa June 28, 2017 -- Findings from a retrospective review focusing on sex difference in thoracic endovascular aneurysm repairs (TEVARs) in the Society for Vascular Surgery Vascular Quality Initiative (VQI) registry from 2011 to 2015 were published by Susan E. Deery, MD, et al in Journal of Vascular Surgery (JVS; 2017;66:2 -- 8)... Wed, 28 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/28/female-sex-studied-as-an-independent-predictor-of-mortality-after-tevar-for-intact-descending-taa FDA Grants Priority Review of 10-mg Dose of Xarelto to Reduce Risk of Recurrent VTE http://evtoday.com/2017/06/28/fda-grants-priority-review-of-10-mg-dose-of-xarelto-to-reduce-risk-of-recurrent-vte June 28, 2017 -- Janssen Research & Development, LLC announced that the US Food and Drug Administration (FDA) accepted for priority review a supplemental new drug application for the company's Xarelto (rivaroxaban) to include a 10-mg once-daily dose for reducing the risk of venous thromboembolism (VTE) after at leas... Wed, 28 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/28/fda-grants-priority-review-of-10-mg-dose-of-xarelto-to-reduce-risk-of-recurrent-vte One-Year CONSEQUENT Data Published for B. Braun's SeQuent Please Over-the-Wire DCB http://evtoday.com/2017/06/28/one-year-consequent-data-published-for-b-brauns-sequent-please-over-the-wire-dcb June 28, 2017 -- The 6- and 12-month angiographic and clinical outcomes from the CONSEQUENT trial were published by Gunnar Tepe, MD, et al online in CardioVascular and Interventional Radiology. The trial evaluated B. Braun's SeQuent Please over-the-wire (OTW) drug-coated balloon (DCB) in femoropopliteal lesions. In e... Wed, 28 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/28/one-year-consequent-data-published-for-b-brauns-sequent-please-over-the-wire-dcb Assessment of International Outcomes of Intact AAA Repair Over 9 Years Published http://evtoday.com/2017/06/28/assessment-of-international-outcomes-of-intact-aaa-repair-over-9-years-published June 28, 2017 -- In European Journal of Vascular and Endovascular Surgery (EJVES), Jacob Budtz-Lilly, MD, et al published findings from an analysis of perioperative mortality after intact abdominal aortic aneurysm (AAA) repair in 11 countries over 9 years (2017;54:13 -- 20). The study was conducted because case mix and o... Wed, 28 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/28/assessment-of-international-outcomes-of-intact-aaa-repair-over-9-years-published FDA Approves Bevyxxa for Hospital and Extended-Duration VTE Prevention in Acutely Ill Patients http://evtoday.com/2017/06/28/fda-approves-bevyxxa-for-hospital-and-extended-duration-vte-prevention-in-acutely-ill-patients June 28, 2017 -- Portola Pharmaceuticals Inc. recently announced that the US Food and Drug Administration (FDA) has approved Bevyxxa (betrixaban) for hospital and extended-duration prophylaxis (35 to 42 days) of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk for thro... Wed, 28 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/28/fda-approves-bevyxxa-for-hospital-and-extended-duration-vte-prevention-in-acutely-ill-patients Merit Medical's Embosphere Microspheres Gain FDA Indication for Prostatic Artery Embolization http://evtoday.com/2017/06/22/Merit-Medical-Embosphere-Microspheres-Gain-FDA-Indication-for-Prostatic-Artery-Embolization June 22, 2017 -- Merit Medical Systems, Inc. announced that it has received 513(f)(2) (de novo) classification from the US Food and Drug Administration (FDA) to expand the indication for the company's Embosphere microspheres. The indication now includes prostatic artery embolization (PAE) for symptomatic benign prostati... Thu, 22 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/22/Merit-Medical-Embosphere-Microspheres-Gain-FDA-Indication-for-Prostatic-Artery-Embolization Walk Vascular's Jeti Thrombectomy System Approved in United States and Europe http://evtoday.com/2017/06/21/walk-vasculars-jetithrombectomy-systemapproved-in-united-states-and-europe June 21, 2017 -- Walk Vascular, LLC announced US Food and Drug Administration clearance and European CE Mark approval of its Jeti thrombectomy system, which is indicated for use in the peripheral vasculature. The company has begun a limited commercial release of the 8-F catheter in North America and Western Europe, with pla... Wed, 21 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/21/walk-vasculars-jetithrombectomy-systemapproved-in-united-states-and-europe Key Milestones Announced for Shockwave Medical's Lithoplasty System in Treatment of PAD http://evtoday.com/2017/06/21/key-milestones-announced-for-shockwave-medicals-lithoplasty-system-in-treatment-of-pad June 21, 2017 -- Shockwave Medical, Inc. announced two milestones for its Lithoplasty system for the treatment of calcified plaque in patients with peripheral artery disease (PAD). The Lithoplasty system is designed to treat calcified artery blockages in the leg with lithotripsy, sonic pressure waves historically used to tr... Wed, 21 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/21/key-milestones-announced-for-shockwave-medicals-lithoplasty-system-in-treatment-of-pad German Study Demonstrates Benefit of Embolic Protection for Carotid Stenting http://evtoday.com/2017/06/20/german-study-demonstrates-benefit-of-embolic-protection-for-carotid-stenting June 20, 2017 -- An analysis of a German database evaluating carotid artery stenting procedures concluded that the use of an embolic protection device was independently associated with lower in-hospital risk for stroke or death, major stroke or death, and stroke. The study was published by Christoph Knappich, MD, et al onli... Tue, 20 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/20/german-study-demonstrates-benefit-of-embolic-protection-for-carotid-stenting SVS Elects New Leadership for 2017–2018 http://evtoday.com/2017/06/20/svs-elects-new-leadership-for-20172018 June 20, 2017 -- The Society for Vascular Surgery (SVS) announced the election of the 2017 -- 2018 leadership at the business meeting held during the SVS Vascular Annual Meeting earlier this month in San Diego, California. The SVS President for 2017 -- 2018 is R. Clement Darling, III, MD, who served as President-Elect du... Tue, 20 Jun 2017 04:00:00 GMT http://evtoday.com/2017/06/20/svs-elects-new-leadership-for-20172018